281 related articles for article (PubMed ID: 15256386)
1. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
[TBL] [Abstract][Full Text] [Related]
2. Beryllium-stimulated apoptosis in macrophage cell lines.
Sawyer RT; Fadok VA; Kittle LA; Maier LA; Newman LS
Toxicology; 2000 Aug; 149(2-3):129-42. PubMed ID: 10967410
[TBL] [Abstract][Full Text] [Related]
3. Beryllium induces apoptosis in human lung macrophages.
Kittle LA; Sawyer RT; Fadok VA; Maier LA; Newman LS
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):101-13. PubMed ID: 12102605
[TBL] [Abstract][Full Text] [Related]
4. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
Tinkle SS; Kittle LA; Newman LS
J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
[TBL] [Abstract][Full Text] [Related]
5. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
[TBL] [Abstract][Full Text] [Related]
6. Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.
Li L; Hamzeh N; Gillespie M; Elliott J; Wang J; Gottschall EB; Mroz PM; Maier LA
PLoS One; 2015; 10(2):e0117276. PubMed ID: 25689051
[TBL] [Abstract][Full Text] [Related]
7. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.
Huang H; Meyer KC; Kubai L; Auerbach R
Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444
[TBL] [Abstract][Full Text] [Related]
8. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
Tinkle SS; Newman LS
Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
[TBL] [Abstract][Full Text] [Related]
9. Beryllium induces IL-2 and IFN-gamma in berylliosis.
Tinkle SS; Kittle LA; Schumacher BA; Newman LS
J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
[TBL] [Abstract][Full Text] [Related]
11. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
Fontenot AP; Kotzin BL; Comment CE; Newman LS
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
[TBL] [Abstract][Full Text] [Related]
12. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
[TBL] [Abstract][Full Text] [Related]
13. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
[TBL] [Abstract][Full Text] [Related]
14. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
[TBL] [Abstract][Full Text] [Related]
15. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease.
Sawyer RT; Fontenot AP; Barnes TA; Parsons CE; Tooker BC; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Hagman J; Newman LS
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):191-200. PubMed ID: 16980557
[TBL] [Abstract][Full Text] [Related]
16. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
[TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.
Dobis DR; Sawyer RT; Gillespie MM; Newman LS; Maier LA; Day BJ
Am J Respir Cell Mol Biol; 2010 Oct; 43(4):458-64. PubMed ID: 19901345
[TBL] [Abstract][Full Text] [Related]
18. [Structural and functional-metabolic criteria for studies of bronchial lavage cells in beryllium production workers].
Bazeliuk LT; Sadykov KB
Med Tr Prom Ekol; 2011; (8):12-6. PubMed ID: 22180971
[TBL] [Abstract][Full Text] [Related]
19. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
[TBL] [Abstract][Full Text] [Related]
20. Immunologic specificity of lymphocyte cell lines from dogs exposed to beryllium oxide.
Haley PJ; Swafford DS; Finch GL; Hoover MD; Muggenburg BA; Johnson NF
Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):459-71. PubMed ID: 9436046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
